Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Lonza to Co-distribute MycoTool Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche and Lonza today announced an exclusive co-distribution deal for the commercialization of Roche's MycoTool mycoplasma PCR assays.

As a result, MycoTool kits are now available from Lonza for final release testing for pharmaceutical products upon validation. Lonza also offers contract testing services using the MycoTool test, which is the first commercial nucleic acid testing-based detection system for mycoplasma biosafety testing of approved biological products, the two firms said.

Financial and other terms of the deal were not disclosed.

Release testing with the MycoTool PCR-based test from Roche Custom Biotech has been approved by the European Medicines Agency for several pharmaceutical products. The test is the first commercially available mycoplasma PCR-based test for replacing traditional mycoplasma tests, which use cell-dependent and cell-independent culture methods during pharmaceutical production, Roche and Lonza said.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.